Molecular Formula | C18H36O10 |
Molar Mass | 412.47 |
Density | 1.111±0.06 g/cm3(Predicted) |
Boling Point | 503.0±50.0 °C(Predicted) |
pKa | 4.28±0.10(Predicted) |
Storage Condition | -20°C |
In vitro study | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
use | 4,7,10,13,16,19,22,25-octaoxane acid is used to detect antibiotic residues by nano-gold probe surface plasmon resonance method. |
biological activity | m-PEG7-CH2COOH is a non-cleavable ADC linker used in the synthesis of antibody-coupled drugs (ADC). m-PEG7-CH2COOH is also a PEG-based PROTAC linker, which can be used for PROTAC synthesis. |
target | Non-cleavable PEGs |
in vitro study | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |